Shares of Proteome Sciences plc (LON:PRM – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 3.45 ($0.05) and traded as low as GBX 2.60 ($0.03). Proteome Sciences shares last traded at GBX 2.60 ($0.03), with a volume of 507,023 shares trading hands.
Proteome Sciences Stock Down 10.0 %
The business’s 50 day simple moving average is GBX 3.90 and its 200 day simple moving average is GBX 3.45. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The firm has a market capitalization of £7.67 million, a PE ratio of -1.88 and a beta of 0.07.
Proteome Sciences (LON:PRM – Get Free Report) last issued its quarterly earnings data on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- What to Know About Investing in Penny Stocks
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- How to Plot Fibonacci Price Inflection Levels
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.